1031 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Not yet recruiting A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors
Conditions: Triple-Negative Breast Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Head and Neck Carcinoma, Squamous Cell;   Advanced Solid Tumors
Interventions: Drug: TAK-659;   Drug: Nivolumab
22 Recruiting Effect of TTFields in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery
Condition: Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Interventions: Device: NovoTTF-100M device;   Other: Best Standard of Care
23 Not yet recruiting Trial of Stereotactic Body Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma
Conditions: Lung Squamous Cell Carcinoma Stage IV;   Nonsquamous Nonsmall Cell Neoplasm of Lung
Interventions: Biological: ADV/HSV-tk;   Drug: Valacyclovir;   Radiation: SBRT;   Drug: nivolumab
24 Not yet recruiting A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer
Condition: Stage IV Non-small Cell Lung Cancer
Interventions: Drug: Ramucirumab;   Drug: Docetaxel
25 Recruiting PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Biological: blood sample collection for CTC and MDSC analysis
26 Not yet recruiting A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Napabucasin;   Drug: Paclitaxel
27 Not yet recruiting Pembrolizumab + CVA21 in Advanced NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Pembrolizumab;   Biological: CVA21
28 Recruiting A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations
Condition: EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors
Interventions: Drug: Apatinib;   Drug: Gefitinib;   Drug: Placebo
29 Not yet recruiting TG4010 and Nivolumab in Patients With Lung Cancer
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage I Non-Small Cell Lung Cancer;   Stage II Non-Small Cell Lung Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Biological: TG4010;   Biological: Nivolumab
30 Recruiting Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy
Condition: Non Small Cells Lung Cancer
Intervention: Biological: PCT dosage
31 Recruiting Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Procedure: Parametric Imaging
32 Recruiting The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation
Condition: Non-small Cell Lung Cancer(NSCLC)
Intervention: Drug: Icotinib
33 Not yet recruiting A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Delta-Like Protein 3-Expressing Extensive Stage Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: Rovalpituzumab Tesirine;   Drug: Cisplatin;   Drug: Etoposide
34 Recruiting Dexamethasone Effects in Patients With Refractory Advanced Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Dexamethasone;   Device: Device for PET;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
35 Not yet recruiting Neoadjuvant Pembrolizumab
Condition: Non-small Cell Lung Carcinoma
Intervention: Drug: Pembrolizumab
36 Recruiting Universal Cancer Peptide-based Vaccination in Metastatic NSCLC
Condition: Metastatic Non-small Cell Lung Cancer
Intervention: Drug: UCPVax
37 Not yet recruiting Trial of BMS-986012 in Combination With Platinum and Etoposide
Condition: Small Cell Lung Cancer
Interventions: Drug: BMS-986012;   Drug: Cisplatin;   Drug: Etoposide;   Drug: Platinum;   Drug: Carboplatin
38 Not yet recruiting Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
Condition: Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
Intervention: Drug: Chidamide with EGFR-TKI
39 Recruiting A Study of Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy [IMpower210]
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody;   Drug: Docetaxel
40 Not yet recruiting Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Drug: Nivolumab + Plinabulin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years